Venkys (India) Ltd Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 24 May 2026 | Food Products | Market Cap: ₹2.2K Cr
Poultry segment growth expected at 7%-8% industry level; Venky's also plans internal growth in layers and broilers. Animal Health division expected to grow at double-digit rates, with 15%-20% growth guidance for FY27.
From Venkys (India) Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Price
₹1,507
Market Cap
₹2.2K Cr
P/E Ratio
12.4
Revenue Rank
Margin Rank
How does Venkys (India) Ltd rank in Food Products?
Compare Venkys (India) Ltd against every Food Products company this quarter on revenue, margins and earnings-call signals.
Venkys (India) Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹1.1K Cr, net profit ₹101 Cr.
Full financials →📊 Revenue & Sales Performance
Rank 3📈 Profitability & Margins
Rank 3- →Animal Health division expected to grow at double-digit rates, with 15%-20% growth guidance for FY27. Margins likely to sustain at 22%-23%+ despite some raw material cost pressures (Pages 16, 19).
- →Soya/Oil Seed division showing improved margins and volumes, targeting increased external sales (up to 65% outside group), hence better profitability; sustainable EBIT margin around 5%, with optimism for growth linked to better crops and export markets (Pages 16, 17).
- →Poultry division growth aligned with industry growth of 7%-8%, with some seasonality expected; volatility expected to reduce due to industry maturation and consistent placement practices (Pages 4, 18).
- →SPF egg division capacity utilization improving (48%) with scope for higher realization and margins, though precise margin outlook to be provided later (Page 16).
- →Overall, combined EBITDA run rate from Animal Health and Soya projected around INR160-180 crores, with top-line and margin expansion expected across segments (Page 16).
🏗️ Capital Expenditure Plans
No- →Venky's plans to focus on strengthening existing units over the next year before considering further capex.
- →No immediate plans for increasing working capital or term loans; sufficient working capital (~INR160 crores) is in place.
- →No specific announcements about new capex in Oil Processing; current capacity utilization is improving with expectations to reach ~80%.
- →The company is cautious about adding new liabilities or investments amidst volatile raw material pricing.
- →Expansion in distribution channels for Animal Health is underway, but no direct capex details shared.
- →Management is exploring export opportunities but did not specify capital allocation.
- →Future capex decisions, including geographic expansion in Oil Processing, will be considered after stabilizing current facilities.
💰 Fundraising & Capital Structure
No- →As per the management discussion on Page 19, there are **no current plans to increase liabilities** either through term loans or working capital loans.
- →The company currently has sufficient working capital availability of around INR160 crores to meet requirements.
- →On the capital expenditure front, the company intends to focus on strengthening existing units before considering any further capex (Page 14).
- →No mention of any upcoming equity fundraising or share buyback programs was confirmed, though shareholder suggestions on buyback have been noted and will be considered (Page 13).
- →Overall, Venky's India Limited is maintaining a conservative approach toward debt and capital infusion, with no immediate fundraising plans through debt or equity.
📋 Order Book & Pipeline
No informationKey Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Frequently Asked Questions
What were Venkys (India) Ltd Q4 FY26 results?
Poultry segment growth expected at 7%-8% industry level; Venky's also plans internal growth in layers and broilers. Animal Health division expected to grow at double-digit rates, with 15%-20% growth guidance for FY27.
What is Venkys (India) Ltd share price analysis?
Venkys (India) Ltd currently shows a below-average growth signal. The stock trades at a P/E of 12.4 with a market cap of ₹2,153 Cr. Investors should review the full earnings analysis for detailed insights.
Is Venkys (India) Ltd planning capital expenditure?
Venky's plans to focus on strengthening existing units over the next year before considering further capex.
Keep Venkys (India) Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.